Gut-liver axis improves with meloxicam treatment after cirrhotic liver resection

doi:10.3748/wjg.v20.i40.14841

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 40

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6331)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-8) series, Tables (1-3) series.

Item

Count

PDF

412

WORD

271

HTML

3412

Figures (1-8)

159

Tables (1-3)

127

Sum=4381

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

955

Download

995

Sum=1950

Oct 28, 2014 (publication date) through May 1, 2024

Times Cited of This Article

Times Cited (8)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Gastroenterol. Oct 28, 2014; 20(40): 14841-14854
Published online Oct 28, 2014. doi: 10.3748/wjg.v20.i40.14841

Table 1 The microcirculation of the liver, small bowel, and portal venous flow measurements after liver resection for three groups

	CG	BDL + M	BDL	P value
Liver flow (AU)	232 ± 11	207 ± 10	188 ± 11^a	< 0.05^a
Small bowel flow (AU)	323 ± 10	280 ± 21	289 ± 21	NS
PVF (mL/min)	27 ± 3	17 ± 2^a	17 ± 3^a	< 0.05^a

Values are given as mean ± SE; 2-way ANOVA. Bonferroni’s post-test: n = 15,

^aP < 0.05 vs CG. CG: Control group; BDL: Bile duct ligation; BDL + M: BDL + meloxicam; NS: Not significant; AU: Arbitrary unit; PVF: Portal venous flow.

Citation: Hamza AR, Krasniqi AS, Srinivasan PK, Afify M, Bleilevens C, Klinge U, Tolba RH. Gut-liver axis improves with meloxicam treatment after cirrhotic liver resection. World J Gastroenterol 2014; 20(40): 14841-14854
URL: https://www.wjgnet.com/1007-9327/full/v20/i40/14841.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i40.14841